MedTrace Logo

Shaping Care Home COVID-19 Testing Policy

NCT05639205 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2022-12-09

No results posted yet for this study

Summary

The goal of this interventional study is to investigate whether continued use of regular asymptomatic testing in staff is a feasible, effective and cost-effective strategy to reduce the impact of COVID-19 in care homes.

The trial aims to quantify the benefits and harms of regular asymptomatic testing in care home staff to inform policy. The rationale for regular asymptomatic testing is that it may reduce the risk of severe disease in residents and the frequency/severity of outbreaks.

Participants (care home staff) will perform regular asymptomatic tests for Covid-19. Should they test positive they will be required to refrain from working and be provided with sick pay.

Care providers will be reimbursed for the costs of employing agency staff to cover staff sickness absence that results directly from the trial.

Conditions

Interventions

DIAGNOSTIC_TEST

Lateral Flow Device

Regular asymptomatic staff testing with a Lateral Flow Device including support payments if unwell.

Sponsors & Collaborators

  • University College, London

    lead OTHER

Principal Investigators

  • Laura Shallcross, Professor · UCL

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2024-04-30
Completion
2024-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05639205 on ClinicalTrials.gov